Shorla Oncology
Shorla Oncology, a pioneering biopharmaceutical company headquartered in Ireland (IE), is dedicated to transforming cancer treatment through innovative solutions. Founded in 2018, Shorla has rapidly established itself in the oncology sector, focusing on the development of unique formulations and delivery systems for cancer therapies. With a strong presence in both the European and North American markets, Shorla Oncology is committed to addressing unmet medical needs in oncology. Their core products include specialised formulations that enhance the efficacy and safety of existing cancer treatments, setting them apart in a competitive landscape. Recognised for their commitment to quality and innovation, Shorla Oncology continues to make significant strides in improving patient outcomes, solidifying their position as a leader in the biopharmaceutical industry.
DitchCarbon Score
How does Shorla Oncology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shorla Oncology's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shorla Oncology's reported carbon emissions
Shorla Oncology, headquartered in Ireland (IE), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Shorla Oncology may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it will be essential for Shorla Oncology to establish clear commitments and measurable targets to align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shorla Oncology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
